(R)-2-(((Benzyloxy)carbonyl)amino)hexanoic acid, 95.0%, 25g

N,N,N',N'-Ethylenediaminetetrakis(methylenephosphonic Acid)>95.0%(T)100g

(S)-METHYL 1-CBZ-PIPERIDINE-3-CARBOXYLATE, 95.0%, 250mg

1,1'-Bis(dicyclohexylphosphino)ferrocene>97.0%(HPLC)(T)5g

2-(Isopropylamino)ethanol>99.0%(GC)(T)100mL

GC capillary column ROTI®Cap-1, 50 m, 0.25 mm, 0.50 µm, 1 Piece(s)

2-Chloro-3-phenylquinoxaline>98.0%(GC)200mg

Methyl 3-(3-cyanophenyl)-3-oxopropanoate, 95%, 500mg

(3R,4S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-3-carboxylic acid, 97%, 1g

Ethyl ureidoacetate, 5g

((3aR,6S,6aR)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5,5-diyl)dimethanol, 95.0%, 25g

(1R,2R)-1,2-Cyclohexanedicarboxylic Acid>98.0%(GC)(T)1g

Ethyl 6-oxo-4-(trifluoromethyl)-1,6-dihydropyridazine-3-carboxylate, 97%, 500mg